|
1 Guan N, Ding J, Zhang J, et al. Key molecular events in puromycin aminonucleoside nephrosis rats. Pathol Int,2004,54(9):703-711.
|
|
2 Xing Y, Ding J, Fan Q, et al. Increased expression of podocyte molecules might cause proteinuria in adriamycin-induced nephrotic rats. Chin J Nephrol,2006,22(1):27-32.[邢燕,丁洁,范青锋等.足细胞分子高表达致阿霉素肾病大鼠发生蛋白尿.中华肾脏病杂志,2006,22(1):27-32.]
|
|
3 Roselli S, Heidet L, Sich M, et al. Early glomerular filtration defect and severe renal disease in podocin-deficient mice. Mol Cell Biol,2004,24(2):550-560.
|
|
4 Zhou W, Chen N,Pan XX, et al. Glomerular expression of podocin in patients with nephrotic syndrome. Chin J Nephrol,2005,21(9):502-505.[周伟,陈楠,潘晓霞等.肾病综合征患者肾组织podocin的表达.中华肾脏病杂志,2005,21(9):502-505.]
|
|
5 Nakatsue T, Koike H, Han GD, et al. Nephrin and podocin dissociate at the onset of proteinuria in experimental membranous nephropathy. Kidney Int,2005,67(6):2239-2253.
|
|
6 Chen ZH, Liu ZH,Sun H, et al. Triptolid ameliorate podocyte injury induced by puromycin am inonucleoside in vitro. J Nephrol Dialy Transplant,2007,16(2):119-126.[陈朝红,刘志红,孙骅等.雷公藤甲素干预足细胞病变的体外观察.肾脏病与透析肾移植杂志,2007,16(2):119-126.]
|
|
7 Kanjanabuch T, Ma LJ, Chen J, et al. PPAR-gamma agonist protects podocytes from injury. Kidney Int,2007,71(12):1232-1239.
|
|
8 Wada T, Pippin JW, Marshall CB, et al. Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: Role of p53 and Bcl-2-related family proteins. J Am Soc Nephrol, 2005,16(9):2615-2625.
|
|
9 Rico M, Mukherjee A, Konieczkowski M, et al. WT1-interacting protein and ZO-1 translocate into podocyte nuclei after puromycin aminonucleoside treatment. Am J Physiol Renal Physiol, 2005,289(2):F431-441.
|
|
10 Ransom RF, Lam NG, Hallett MA, et al. Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization. Kidney Int, 2005,68(6):2473-2483.
|
|
11 Shibata S, Nagase M, Fujita T. Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling. J Am Soc Nephrol,2006,17(3):754-764.
|
|
12 Wang L, Ellis MJ, Fields TA, et al. Beneficial effects of the Rho kinase inhibitor Y27632 in murine puromycin aminonucleoside nephrosis. Kidney Blood Press Res,2008,31(2):111-121.
|
|
13 Hosoyamada M, Yan K, Nishibori Y, et al. Nephrin and podocin expression around the onset of puromycin aminonucleoside nephrosis. J Pharmacol Sci,2005,97(2):234-241.
|
|
14 Richard JM, Coward, Rebecca R, et al. Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, podocin, CD2AP associated protein in cultured human podocytes. J Am Soc Nephrol,2005,16(3):629-637.
|
|
15 Roselli S, Moutkine I, Gribouval O, et al. Plasma membrane targeting of podocin through the classical exocytic pathway:Effect of NPHS2 mutations. Traffic,2004,5(1):37-44.
|
|
16 Benedetta B, Maria CD, Valentina F, et al. Statins prevent oxidized LDL-induced injury of glomerular podocytes by activating the phosphatidylinositol 3-kinase/Akt-signaling pathway. J Am Soc Nephrol,2005,16(7):1936-1947.
|
|
17 Zhu J, Sun N, Aoudjit L, et al. Nephrin mediates actin reorganization via phosphoinositide 3-kinase in podocytes. Kidney Int,2008,73(5):556-566.
|
|
18 Koshikawa M, Mukoyama M, Mori K, et al. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.J Am Soc Nephrol 2005,16(9):2690-2701.
|
|
19 Fan Q, Ding J, Zhang J, et al. Effect of the knockdown of podocin mRNA on nephrin and alpha-actinin in mouse podocyte. Exp Biol Med (Maywood),2004,229(9):964-970.
|
|
20 Fan Q, Xing Y, Ding J, et al. The relationship among nephrin, podocin, CD2AP, and alpha-actinin might not be a true "interaction" in podocyte. Kidney Int,2006,69(7):1207-1215.
|